Suppr超能文献

非酒精性脂肪性肝病是小鼠体内过氯乙烯诱导肝效应的易感因素。

Nonalcoholic Fatty Liver Disease Is a Susceptibility Factor for Perchloroethylene-Induced Liver Effects in Mice.

机构信息

Department of Veterinary Integrative Biosciences, Texas A&M University, College Station, Texas 77843.

Texas A&M Institute for Genome Sciences and Society, Texas A&M University, College Station, Texas 77843.

出版信息

Toxicol Sci. 2017 Sep 1;159(1):102-113. doi: 10.1093/toxsci/kfx120.

Abstract

Nonalcoholic fatty liver disease (NAFLD) is the most prevalent pathological liver condition in developed countries. NAFLD results in severe alterations in liver function, including xenobiotic metabolism. Perchloroethylene (PERC) is a ubiquitous environmental pollutant, a known hepatotoxicant in rodents, and a probable human carcinogen. It is known that PERC disposition and metabolism are affected by NAFLD in mice; here, we examined how NAFLD changes PERC-associated liver effects. Male C57Bl6/J mice were fed a low-fat diet (LFD), high-fat diet (HFD), or methionine/folate/choline-deficient diet (MCD) to model a healthy liver, or mild and severe forms of NAFLD, respectively. After 8 weeks on diets, mice were orally administered PERC (300 mg/kg/day) or vehicle (5% aqueous Alkamuls-EL620) for 5 days. PERC-induced liver effects were exacerbated in both NAFLD groups. PERC exposure was associated with up-regulation of genes involved in xenobiotic, lipid, and glutathione metabolism, and down-regulation of the complement and coagulation cascades, regardless of the diet. Interestingly, HFD-fed mice, not MCD-fed mice, were generally more sensitive to PERC-induced liver effects. This was indicated by histopathology and transcriptional responses, where induction of genes associated with cell cycle and inflammation were prominent. Liver effects positively correlated with diet-specific differences in liver concentrations of PERC. We conclude that NAFLD alters the toxicodynamics of PERC and that NAFLD is a susceptibility factor that should be considered in future risk management decisions for PERC and other chlorinated solvents.

摘要

非酒精性脂肪性肝病(NAFLD)是发达国家最常见的肝脏病理状况。NAFLD 导致严重的肝功能改变,包括异生物代谢。全氯乙烯(PERC)是一种普遍存在的环境污染物,在啮齿动物中是一种已知的肝毒物,也是一种可能的人类致癌物。已知 PERC 的处置和代谢在小鼠的 NAFLD 中受到影响;在这里,我们研究了 NAFLD 如何改变 PERC 相关的肝脏效应。雄性 C57Bl6/J 小鼠分别用低脂饮食(LFD)、高脂饮食(HFD)或蛋氨酸/叶酸/胆碱缺乏饮食(MCD)喂养 8 周,以分别建立健康肝脏或轻度和重度 NAFLD 模型。在饮食 8 周后,小鼠经口给予 PERC(300mg/kg/天)或载体(5%水性 Alkamuls-EL620)5 天。两种 NAFLD 组的 PERC 诱导的肝脏效应均加剧。无论饮食如何,PERC 暴露均与参与异生物、脂质和谷胱甘肽代谢的基因上调以及补体和凝血级联下调有关。有趣的是,HFD 喂养的小鼠而非 MCD 喂养的小鼠通常对 PERC 诱导的肝脏效应更为敏感。这从组织病理学和转录反应中可以看出,与细胞周期和炎症相关的基因的诱导更为明显。肝脏效应与 PERC 肝脏浓度的饮食特异性差异呈正相关。我们得出结论,NAFLD 改变了 PERC 的毒代动力学,NAFLD 是一个易感因素,在未来 PERC 和其他氯化溶剂的风险管理决策中应予以考虑。

相似文献

2
Impact of Nonalcoholic Fatty Liver Disease on Toxicokinetics of Tetrachloroethylene in Mice.
J Pharmacol Exp Ther. 2017 Apr;361(1):17-28. doi: 10.1124/jpet.116.238790. Epub 2017 Feb 1.
4
PBPK modeling of impact of nonalcoholic fatty liver disease on toxicokinetics of perchloroethylene in mice.
Toxicol Appl Pharmacol. 2020 Aug 1;400:115069. doi: 10.1016/j.taap.2020.115069. Epub 2020 May 21.
6
The effects of perfluorooctanoate on high fat diet induced non-alcoholic fatty liver disease in mice.
Toxicology. 2019 Mar 15;416:1-14. doi: 10.1016/j.tox.2019.01.017. Epub 2019 Jan 31.
9
Impact of repeated exposure on toxicity of perchloroethylene in Swiss Webster mice.
Toxicology. 2007 Mar 22;232(1-2):1-14. doi: 10.1016/j.tox.2006.12.018. Epub 2006 Dec 22.
10
Antrodia cinnamomea and its compound dehydroeburicoic acid attenuate nonalcoholic fatty liver disease by upregulating ALDH2 activity.
J Ethnopharmacol. 2022 Jun 28;292:115146. doi: 10.1016/j.jep.2022.115146. Epub 2022 Mar 16.

引用本文的文献

3
PBPK modeling of impact of nonalcoholic fatty liver disease on toxicokinetics of perchloroethylene in mice.
Toxicol Appl Pharmacol. 2020 Aug 1;400:115069. doi: 10.1016/j.taap.2020.115069. Epub 2020 May 21.
6
Mechanisms of Environmental Contributions to Fatty Liver Disease.
Curr Environ Health Rep. 2019 Sep;6(3):80-94. doi: 10.1007/s40572-019-00232-w.
7
Nonalcoholic fatty liver disease alters microcystin-LR toxicokinetics and acute toxicity.
Toxicon. 2019 Apr 15;162:1-8. doi: 10.1016/j.toxicon.2019.03.002. Epub 2019 Mar 5.
9
Role of xenobiotics in the induction and progression of fatty liver disease.
Toxicol Res (Camb). 2018 May 18;7(4):664-680. doi: 10.1039/c7tx00326a. eCollection 2018 Jul 1.
10
Interaction of volatile organic compounds and underlying liver disease: a new paradigm for risk.
Biol Chem. 2018 Oct 25;399(11):1237-1248. doi: 10.1515/hsz-2017-0324.

本文引用的文献

3
Impact of Nonalcoholic Fatty Liver Disease on Toxicokinetics of Tetrachloroethylene in Mice.
J Pharmacol Exp Ther. 2017 Apr;361(1):17-28. doi: 10.1124/jpet.116.238790. Epub 2017 Feb 1.
4
The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe.
Hepatology. 2016 Nov;64(5):1577-1586. doi: 10.1002/hep.28785. Epub 2016 Sep 26.
5
Target Organ Metabolism, Toxicity, and Mechanisms of Trichloroethylene and Perchloroethylene: Key Similarities, Differences, and Data Gaps.
J Pharmacol Exp Ther. 2016 Oct;359(1):110-23. doi: 10.1124/jpet.116.232629. Epub 2016 Aug 10.
6
Comparison of Gene Expression Patterns Between Mouse Models of Nonalcoholic Fatty Liver Disease and Liver Tissues From Patients.
Gastroenterology. 2016 Sep;151(3):513-525.e0. doi: 10.1053/j.gastro.2016.05.051. Epub 2016 Jun 16.
7
Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World.
Clin Liver Dis. 2016 May;20(2):205-14. doi: 10.1016/j.cld.2015.10.001. Epub 2015 Dec 14.
8
Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies.
Nat Rev Drug Discov. 2016 Apr;15(4):249-74. doi: 10.1038/nrd.2015.3. Epub 2016 Jan 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验